Jasper Therapeutics- Warrants (24/09/2026) Accounts Payable

The latest accounts payable for JSPRW is $2.4M as of March 2026. That compares with $3M in the prior-year period — down 18.6% year over year. Investors often review this figure alongside Jasper Therapeutics- Warrants (24/09/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, JSPRW's accounts payable moved from $3M to $2.4M — a 18.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Jasper Therapeutics- Warrants (24/09/2026)'s operating scale or balance-sheet position.

A accounts payable figure of $2.4M for JSPRW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting JSPRW's accounts payable ($2.4M), review year-over-year change from $3M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.